366 related articles for article (PubMed ID: 33340527)
1. Nanotechnology in ovarian cancer: Diagnosis and treatment.
Barani M; Bilal M; Sabir F; Rahdar A; Kyzas GZ
Life Sci; 2021 Feb; 266():118914. PubMed ID: 33340527
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
[TBL] [Abstract][Full Text] [Related]
3. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
Ruiz ME; Gantner ME; Talevi A
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
[TBL] [Abstract][Full Text] [Related]
4. Recent advancements in fabrication of nanomaterial based biosensors for diagnosis of ovarian cancer: a comprehensive review.
Sha R; Badhulika S
Mikrochim Acta; 2020 Feb; 187(3):181. PubMed ID: 32076837
[TBL] [Abstract][Full Text] [Related]
5. Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer.
Rhoda K; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
Expert Opin Drug Deliv; 2015 Apr; 12(4):613-34. PubMed ID: 25300775
[TBL] [Abstract][Full Text] [Related]
6. Current Update on Nanotechnology-Based Approaches in Ovarian Cancer Therapy.
Bhardwaj BK; Thankachan S; Magesh P; Venkatesh T; Tsutsumi R; Suresh PS
Reprod Sci; 2023 Feb; 30(2):335-349. PubMed ID: 35585292
[TBL] [Abstract][Full Text] [Related]
7. The potentials of nanotechnology-based drug delivery system for treatment of ovarian cancer.
Gidwani B; Vyas A
Artif Cells Nanomed Biotechnol; 2015; 43(4):291-7. PubMed ID: 24245788
[TBL] [Abstract][Full Text] [Related]
8. Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery.
Zhang Y; Zhang P; Zhu T
Biomed Pharmacother; 2019 Jan; 109():475-483. PubMed ID: 30399584
[TBL] [Abstract][Full Text] [Related]
9. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
Ho BN; Pfeffer CM; Singh ATK
Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapeutic Efficacy of Implantable Antineoplastic-Treatment Protocols in an Optimal Mouse Model for Human Ovarian Carcinoma Cell Targeting.
Pantshwa JM; Rhoda K; Clift SJ; Pradeep P; Choonara YE; Kumar P; du Toit LC; Penny C; Pillay V
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30287783
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes.
Corradetti B; Pisano S; Conlan RS; Ferrari M
J Pharmacol Exp Ther; 2019 Sep; 370(3):636-646. PubMed ID: 30737357
[TBL] [Abstract][Full Text] [Related]
12. New trends in diagnosing and treating ovarian cancer using nanotechnology.
Zhang J; Ding H; Zhang F; Xu Y; Liang W; Huang L
Front Bioeng Biotechnol; 2023; 11():1160985. PubMed ID: 37082219
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation for Cancer Therapy.
Montané X; Bajek A; Roszkowski K; Montornés JM; Giamberini M; Roszkowski S; Kowalczyk O; Garcia-Valls R; Tylkowski B
Molecules; 2020 Mar; 25(7):. PubMed ID: 32244513
[TBL] [Abstract][Full Text] [Related]
15. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
16. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
17. Implications of nanotechnology for the treatment of cancer: Recent advances.
Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
[TBL] [Abstract][Full Text] [Related]
18. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
Zhang J; Tang H; Liu Z; Chen B
Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
[TBL] [Abstract][Full Text] [Related]
19. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-based targeted drug delivery.
Singh R; Lillard JW
Exp Mol Pathol; 2009 Jun; 86(3):215-23. PubMed ID: 19186176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
